학술논문

Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study
Document Type
Article
Source
In: Cancer Discovery. (Cancer Discovery, 1 August 2023, 13(8):1814-1825)
Subject
Language
English
ISSN
21598290
21598274